BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2003
View Archived Issues
AVI BioPharma plans second AVI-4020 study for West Nile virus
Read More
CytRx to fund UMMS research program of RNAi silencing for ALS
Read More
Investigator meeting precedes phase II study of ProCord
Read More
Doripenem similarly effective against ESBL- and non-ESBL-producing bacteria
Read More
New analgesic agents identified by Schwarz researchers
Read More
GSK antiangiogenic Tie-2 and/or VEGFR2 inhibitors covered by patent
Read More
Novel RT inhibitors prepared and tested at the U. of Pittsburgh and Fluorous Technologies
Read More
PPAR modulators and their use presented in recent patents
Read More
New Abeta production inhibitors/sAPPalpha secretion enhancers discovered at Takeda
Read More
U. of Tennessee team claims novel androgen receptor antagonists
Read More
Recombinant alpha1-antitrypsin enters proof-of-concept study for atopic dermatitis
Read More
Liprostin trial commences in Georgia
Read More
Proteasome inhibitor improves renovascular responses in hypercholesterolemic pigs
Read More
Thymitaq designated orphan drug in E.U. for liver cancer
Read More
License agreement for use of Amplivax in novel HIV vaccine candidate
Read More
Kyowa Hakko licenses KW-3902 rights to NovaCardia
Read More
Millennium commences phase I/II study of MLN-2704 in prostate cancer
Read More
Inspra approved for congestive heart failure in heart attack patients
Read More
Approvable letter for Savient's osteoarthritis pain product
Read More
YKP-1358 cleared to enter clinical testing
Read More
Bactericidal activity of oritavancin reported at IDSA meeting
Read More
Fast track status for TNX-355
Read More
Data discussed at IDSA support further development of dalbavancin
Read More
Safety and pharmacokinetics of single-dose oral glutamine in pediatric oncology patients
Read More
Darifenacin has beneficial effects in bladder function disorders
Read More
Good efficacy and tolerability described for solifenacin in overactive bladder patients
Read More